Health Care & Life Sciences » Pharmaceuticals | Harbin Gloria Pharmaceuticals Co. Ltd.

Harbin Gloria Pharmaceuticals Co. Ltd.

Harbin Gloria Pharmaceuticals Co. Ltd. A
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.05
Market Cap
CNY8.7 B
Shares Outstanding
2.17 B
Public Float
752.28 M

Profile

Address
No. 29 Beijing Road
Harbin Heilongjiang 150025
China
Employees -
Website http://www.gloria.cc
Updated 07/08/2019
Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research and development of biological products. It offers cardiovascular, cerebrovascular and skeletal muscular treatment, and antitumor and nutritional drugs. The company products include creatine phosphate sodium injections, clopidogrel bisulfate tablets, cerebroprotein hydrolysate injections, cervus and cucumis polypeptide injections, calcium levofolinate injections, and potassium and magnesium aspartate injections.

Financials

View All
Created with Highcharts 5.0.14Harbin Gloria Pharmaceuticals Co. Ltd. ANet Income. Fiscal year is January-December. All values CNY Millions.2272274444446776777177173103101261262013201420152016201720180200400600800
Created with Highcharts 5.0.14Harbin Gloria Pharmaceuticals Co. Ltd. ASales/Revenue. Fiscal year is January-December. All values CNY Millions.1 2871 2871 8801 8802 6622 6622 9302 9302 9862 9865 3925 39220132014201520162017201801k2k3k4k5k6k

Ji Zhu
Chairman
Xiu Qiang Diao
Chief Financial Officer & Director